
FLUIDIGM CORP
Acción · US34385P1084 · LAB · A0RADJ (XNAS)
1,07 USD
06.06.2025 20:30
Cotizaciones actuales de FLUIDIGM CORP
Bolsa | Ticker | Moneda | Última operación | Precio | Variación diaria |
---|---|---|---|---|---|
![]() NASDAQ |
LAB
|
USD
|
06.06.2025 20:30
|
1,07 USD
| 0,98 USD
+9,18 %
|
Rendimiento
Día | Semana | Mes | 3 meses | 6 meses | 1 año | 5 años |
---|---|---|---|---|---|---|
0,00 % | 6,96 % | 4,90 % | -7,76 % | -41,21 % | -53,88 % | -70,60 % |
Perfil de la empresa para FLUIDIGM CORP Acción
Fluidigm Corporation creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar reagents, Maxpar direct immune profiling assays, Maxpar on demand reagents, and IMC panel kits for immuno-oncology. The company also provides preparatory instruments, such as Juno systems; and analytical instruments comprising Biomark HD system and EP1 system. In addition, it offers integrated fluidic circuits (IFCs), such as library preparation IFCs, Juno genotyping IFC, dynamic array IFCs, digital array IFCs, and Flex Six IFC; and assays and reagents, including Advanta RNA-Seq NGS library prep kits, Advanta Dx SARS-CoV-2 RT-PCR assays, Advanta Dx COVID-19 EASE assays, delta gene and SNP type assays, access array target-specific primers and targeted sequencing prep primers, and targeted DNA Seq library assays. Further, the company offers single cell microfluidics that comprise C1 systems; preparatory analytical instruments, which include C1 IFCs; and software solutions. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. Fluidigm Corporation has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Mycometrix Corporation and changed its name to Fluidigm Corporation in April 2001. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.
Datos de la empresa
Nombre FLUIDIGM CORP
Empresa Standard BioTools Inc.
Símbolo LAB
Sitio web
https://www.fluidigm.com
Mercado principal
NASDAQ

WKN A0RADJ
ISIN US34385P1084
Tipo de valor Acción
Sector Healthcare
Industria Medical - Diagnostics & Research
CEO Mr. Stephen Linthwaite
Capitalización de mercado 294 Mio
País Estados Unidos de América
Moneda USD
Empleados 0,6 T
Dirección 7000 Shoreline Ct Ste 100, 94080 South San Francisco
Fecha de OPV 2011-02-10
Cambios de identificador
Fecha | De | A |
---|---|---|
06.04.2022 | FLDM | LAB |
Símbolos de cotización
Nombre | Símbolo |
---|---|
Frankfurt | FLB.F |
NASDAQ | FLDM |
NASDAQ | LAB |
Otras acciones
Los inversores que tienen FLUIDIGM CORP también tienen las siguientes acciones en su cartera:
La plataforma financiera MoneyPeak rastrea y analiza inversiones y carteras.
Desde depósitos de valores hasta compras de criptomonedas.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.